John Cornyn (R-TX)
Halting the Epidemic of Addiction and Loss Act of 2025
A Republican bill with 1 Democratic cosponsor · See the cosponsor
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, titled the ``Halting the Epidemic of Addiction and Loss Act of 2025'', aims to change how the Department of Health and Human Services (HHS) refers to drugs used to reverse opioid overdoses. It ensures that references to these drugs are not limited strictly to naloxone. The Secretary of HHS must ensure regulations and guidance include any drug approved under the Federal Food, Drug, and Cosmetic Act for emergency treatment of an opioid overdose. Additionally, the Secretary must update existing references in specific grant programs within one year. These programs include State and Tribal Opioid Response Grants and priority substance use disorder prevention needs grants.
Yes
- Scored +7
Does this do more about addiction and overdose deaths?
The bill strengthens the opioid crisis response by modernizing grant guidance to include all FDA-approved reversal agents beyond just naloxone.
- Scored +5
Does this make health care easier to get in general?
By broadening the definition of reversal agents in grant programs, it may facilitate more flexible and effective emergency treatments for opioid overdoses.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded access to various reversal agents: By ensuring that references to opioid overdose reversal drugs are inclusive of any drug approved for emergency treatment of an opioid overdose rather than just naloxone, the bill allows for a broader range of medical options in HHS grant programs (Section 2(a)).
-
Modernization of grant guidance: The requirement for the Secretary to update existing references in regulations and guidance ensures that grant programs for State and Tribal response to opioid use disorders and priority substance use disorder prevention needs reflect current approved medical treatments (Section 2(b)).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly stated in the text of the bill.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this do more about addiction and overdose deaths? — The bill strengthens the opioid crisis response by modernizing grant guidance to include all FDA-approved reversal agents beyond just naloxone. Does this make health care easier to get in general? — By broadening the definition of reversal agents in grant programs, it may facilitate more flexible and effective emergency treatments for opioid overdoses.
- 7/17/2025
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Maggie HassanDemocrat · New Hampshire